Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- A trio of respiratory viruses is sending people to the hospital in N.J.
- He made his brothers get their arteries checked. Each had advanced heart disease.
- Yibin Kang’s team identifies new path to potential cancer treatments.
- Why a Life-Threatening Sedative Is Being Prescribed More Often for Seniors.
- NJACTS Community Engagement Core Available Services
Categories
- Community (2,445)
- Covid (997)
- CTO Events (6)
- News (3,098)
- Pilots (21)